Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy

Annals of Pharmacotherapy

Volumn 50, Issue 8, 2016, Pages 666-672

  Noormohammadi, Arezo ^a   Forinash, Alicia ^b   Yancey, Abigail ^b   Crannage, Erica ^b   Campbell, Kristin ^c   Shyken, Jaye ^d  

^a VA Outpatient Clinic ^*  (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c Esse Health Southside Family Practice   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcohol; and substance abuse; drug; obstetrics gynecology; pregnancy drug effects; substance abuse; women s health

Indexed keywords

BUPRENORPHINE; METHADONE;

DRUG EFFICACY; DRUG SAFETY; EMBASE; FEMALE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; OPIATE ADDICTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; INFANT; LENGTH OF STAY; NEONATAL ABSTINENCE SYNDROME; NEWBORN; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

BUPRENORPHINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84978531815     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016648367     Document Type: Review

References (18)

1. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAHMSA; 2014. NSDUH SeriesH-48, HHS Publication No. (SMA)14-4863. http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed March 21, 2016.
2. A.AzadG.A.DildyIII. Universal screening for substance abuse at the time of parturition. Am J Obstet Gynecol. 2008;198:e30-e32. doi:10.1016/j.ajog.2007.10.780.
3. J.L.YoungP.R.MartinTreatment of opioid dependence in the setting of pregnancy. Psychiatr Clin North Am. 2012;35:441-460. doi:10.1016/j.psc.2012.03.008.
4. C.S.BroussardS.A.RasmussenJ.Reefhuis. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204:314.e1-e11. doi:10.1016/j.ajog.2010.12.039.
5. Center for Substance Abuse Treatment. Medication-assisted treatment for opioid addiction during pregnancy. In: SAHMSA/CSAT Treatment Improvement Protocols. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008:chap 13. http://www.ncbi.nlm.nih.gov/books/NBK26113. Accessed March 21, 2016.
6. M.L.HudakR.C.Tan; Committee on Drugs, Committee on Fetus and Newborn. Neonatal drug withdrawal. Pediatrics. 2012;129:e540-e560. doi:10.1542/peds.2011-3212.
7. A.E.BurgosB.L.BurkeNeonatal abstinence syndrome. NeoReviews. 2009;10:e222-e229. doi:10.1542/neo/10/5-e222.
8. Dolophine (methadone) tablet [product information].Columbus, OH: Roxane Laboratories Inc; 2015.
9. Methadone [clinical pharmacology].Tampa, FL: Gold Standard; 2016. http://www.clinicalpharmacology.com. Accessed March 24, 2016.
10. Buprenorphine: Lexicomp Online. Hudson, OH: Lexi-Comp, Inc; 2016. http://online.lexi.com. Accessed March 24, 2016.
11. A.M.TrescotS.DattaM.LeeH.HansenOpioid pharmacology. Pain Physician. 2008;11:S133-S153.
12. Subutex (buprenorphine) [product information].Columbus, OH: Roxane Laboratories Inc; 2015.
13. American College of Obstetricians and Gynecologists. Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119:1070-1076. doi:10.1097/AOG.0b013e318256496e.
14. G.FischerR.OrtnerK.Rohrmeister. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101:275-281. doi:10.1111/j.1360-0443.2006.01321.x.
15. H.E.JonesR.E.JohnsonD.R.Jasinski. Buprenorphine versus methadone in the treatment of pregnant opioid dependent patient: effects on the neonatal abstinence syndrome (PROMISE Study). Drug Alcohol Depend. 2005;79:1-10. doi:10.1016/j.drugalcdep.2004.11.013.
16. H.E.JonesK.KaltenbackS.H.Heil. Neonatal abstinence syndrome after methadone or buprenorphine exposure (MOTHER Study). N Engl J Med. 2010;363:2320-2331. doi:10.1056/NEJMoa1005359.
17. S.L.WiegandE.M.StringerA.M.StuebeH.JonesC.SeashoreJ.ThorpBuprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol. 2015;125:363-368. doi:10.1097/AOG.0000000000000640.
18. V.MetzR.JagschN.Ebner. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Hum Psychopharmacol. 2011;26:412-421. doi:10.1002/hup.1224.